[Biopharmaceutical and clinico-pharmacological research on the intramammary preparation Cephamasten].
An animal drug formula, Cephamasten, for intramammary application in the treatment of mastitis-affected cows, ewes, and goats in the lactation period was worked out on the base of microbiologic, technologic, biopharmaceutic, and clinico-pharmacologic studies. Its active ingredient was the Pharmachim cephalexin-monohydrate. The consistence of Cephamasten has proved suitable for intracisternal introduction. It is tolerated well within the udder of cows, and it rapidly releases the antibiotic incorporated in it. The milk of the treated quarters has proved free from cephalexin after the 72nd hour of the last infusion. Cephamasten has shown high effectiveness in the treatment both of the preclinical and of the acute clinical mastitis. In the first case best results were obtained with the twofold treatment at a 24-hour interval, and in the second case--with the sixfold treatment at 12-hour intervals (intracisternal introduction of the preparation). In the case of generalized mastitis, in dependence on the severity of the process Cephamasten is to be applied at 4-6-12 intervals along with frequent milking and the parenteral application of other agents.
D000818:Animals; D001702:Biopharmaceutics; D002417:Cattle; D002506:Cephalexin / Q000494:pharmacology* / Q000627:therapeutic use; D004341:Drug Evaluation / Q000662:veterinary; D005260:Female; D006041:Goats; D008413:Mastitis / Q000188:drug therapy / Q000662:veterinary; D008414:Mastitis, Bovine / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D008894:Milk Proteins / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy; D013997:Time Factors
D008894:Milk Proteins; D002506:Cephalexin
Biofarmatsevtichni i klinikofarmakologichni prouchvaniia na intramamarniia preparat tsefamasten.